ANEB icon

Anebulo Pharmaceuticals

14 hedge funds and large institutions have $18.6M invested in Anebulo Pharmaceuticals in 2023 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
14
Holders Change
+2
Holders Change %
+16.67%
% of All Funds
0.21%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.01%
New
4
Increased
4
Reduced
3
Closed
2
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
2L
1
22NW LP
Washington
$13M +$726K +300,000 +6%
Morgan Stanley
2
Morgan Stanley
New York
$1.93M +$1.93M +798,438 New
LA
3
LVW Advisors
New York
$1.56M -$70.9K -29,292 -4%
NCM
4
Nantahala Capital Management
Connecticut
$1.24M
IC
5
Ikarian Capital
Texas
$382K
Vanguard Group
6
Vanguard Group
Pennsylvania
$370K +$316K +130,659 +585%
BFM
7
Boothbay Fund Management
New York
$45.9K
LCM
8
Landscape Capital Management
New Jersey
$36.3K +$36.3K +15,000 New
TRCT
9
Tower Research Capital (TRC)
New York
$22K -$28.4K -11,749 -56%
BlackRock
10
BlackRock
New York
$10K -$116 -48 -1%
ACM
11
ADAR1 Capital Management
Texas
$2.95K +$2.95K +1,217 New
Wells Fargo
12
Wells Fargo
California
$148 +$7 +3 +5%
Bank of America
13
Bank of America
North Carolina
$10 +$10 +4 New
MP
14
Mangrove Partners
Connecticut
-$1.22M -399,219 Closed
PP
15
Praetorian PR
Puerto Rico
-$542K -177,292 Closed